Anticoagulation in atrial fibrillation. A large real-world update

Mario Bo; Stefano Fumagalli; Luca Degli Esposti; Valentina Perrone; Melania Dovizio; Daniela Poli; Rossella Marcucci; Paolo Verdecchia; Gianpaolo Reboldi; Professor Gregory Lip; Andrea Ungar; Alessandro Boccanelli; Carlo Fumagalli; Niccolò Marchionni

doi:10.1016/j.ejim.2023.10.010

Abstract

1 min read

Beyond confirming the association with a better net clinical benefit of DOACs over VKAs, our findings substantiate the large proportion of NVAF patients still inappropriately anticoagulated, thereby reinforcing the need for educational programs.

Related publications

Article2024

Safety and effectiveness of oral anticoagulants in patients with atrial fibrillation and stage 4 chronic kidney disease: a real-world experience

Rosa Talerico, Elisa Brando, Lorenzo Luzi, Maria Cristina Vedovati, Michela Giustozzi, Melina Verso, Leonardo Di Gennaro, Maria Basso, Antonietta Ferretti, Angelo Porfidia, Erica De Candia, Roberto Pola, Giancarlo Agnelli, Cecilia Becattini

Article2025

Direct oral anticoagulants in very elderly and high-bleeding-risk patients with atrial fibrillation often excluded from oral anticoagulation therapy: a nationwide population-based cohort study.

Y. Go, So-Ryoung Lee, Hyo‐Jeong Ahn, Kyungdo Han, Seil Oh, Professor Gregory Lip

Article2023

Short and long-term renal function changes with direct oral anticoagulants in elderly patients with atrial fibrillation

Giuseppe Armentaro, Graziella D’Arrigo, Mario Bo, Velia Cassano, Sofia Miceli, Annalisa Pitino, Giovanni Tripepi, Giorgio Sesti, Professor Gregory Lip, Daniele Pastori, Mercedes Gori, Angela Sciacqua

Article2024

Comparing the Real-World and Clinical Trial Bleeding Rates Associated with Oral Anticoagulation Treatment for Atrial Fibrillation

Ying X. Gue, Dan Bloomfield, Debra Freedholm, Professor Gregory Lip

Article2016

Major bleeding risk among non‐valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban or warfarin: a “real‐world” observational study in the United States

Professor Gregory Lip, Xianying Pan, Shital Kamble, Hugh Kawabata, Jack Mardekian, Cristina Masseria, Amanda Bruno, Hemant Phatak